# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0000950170-23-064005
Filing Date
2023-11-15
Accepted
2023-11-15 07:05:40
Documents
48
Period of Report
2023-11-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | alks-20231113.htm iXBRL | 8-K | 90185
2 | EX-2.1 | alks-ex2_1.htm | EX-2.1 | 880918
3 | EX-10.1 | alks-ex10_1.htm | EX-10.1 | 464688
4 | EX-10.2 | alks-ex10_2.htm | EX-10.2 | 362811
5 | EX-10.3 | alks-ex10_3.htm | EX-10.3 | 372255
6 | EX-10.4 | alks-ex10_4.htm | EX-10.4 | 362352
7 | EX-99.1 | alks-ex99_1.htm | EX-99.1 | 93063
8 | EX-99.2 | alks-ex99_2.htm | EX-99.2 | 25899
9 | EX-99.3 | alks-ex99_3.htm | EX-99.3 | 1205055
10 | GRAPHIC | alks-ex99_2s1.jpg | GRAPHIC | 138665
11 | GRAPHIC | alks-ex99_2s2.jpg | GRAPHIC | 876078
12 | GRAPHIC | alks-ex99_2s3.jpg | GRAPHIC | 287677
13 | GRAPHIC | alks-ex99_2s4.jpg | GRAPHIC | 342125
14 | GRAPHIC | alks-ex99_2s5.jpg | GRAPHIC | 108528
15 | GRAPHIC | alks-ex99_2s6.jpg | GRAPHIC | 474718
16 | GRAPHIC | alks-ex99_2s7.jpg | GRAPHIC | 399738
17 | GRAPHIC | alks-ex99_2s8.jpg | GRAPHIC | 395560
18 | GRAPHIC | alks-ex99_2s9.jpg | GRAPHIC | 369282
19 | GRAPHIC | alks-ex99_2s10.jpg | GRAPHIC | 338232
20 | GRAPHIC | alks-ex99_2s11.jpg | GRAPHIC | 341718
21 | GRAPHIC | alks-ex99_2s12.jpg | GRAPHIC | 397686
22 | GRAPHIC | alks-ex99_2s13.jpg | GRAPHIC | 403732
23 | GRAPHIC | alks-ex99_2s14.jpg | GRAPHIC | 316331
24 | GRAPHIC | alks-ex99_2s15.jpg | GRAPHIC | 246113
25 | GRAPHIC | alks-ex99_2s16.jpg | GRAPHIC | 129085
26 | GRAPHIC | alks-ex99_2s17.jpg | GRAPHIC | 454875
27 | GRAPHIC | alks-ex99_2s18.jpg | GRAPHIC | 456009
28 | GRAPHIC | alks-ex99_2s19.jpg | GRAPHIC | 340152
29 | GRAPHIC | alks-ex99_2s20.jpg | GRAPHIC | 496154
30 | GRAPHIC | alks-ex99_2s21.jpg | GRAPHIC | 370607
31 | GRAPHIC | alks-ex99_2s22.jpg | GRAPHIC | 352884
32 | GRAPHIC | alks-ex99_2s23.jpg | GRAPHIC | 283387
33 | GRAPHIC | alks-ex99_2s24.jpg | GRAPHIC | 299048
34 | GRAPHIC | alks-ex99_2s25.jpg | GRAPHIC | 382082
35 | GRAPHIC | alks-ex99_2s26.jpg | GRAPHIC | 139868
36 | GRAPHIC | alks-ex99_2s27.jpg | GRAPHIC | 355785
37 | GRAPHIC | alks-ex99_2s28.jpg | GRAPHIC | 138315
| Complete submission text file | 0000950170-23-064005.txt |  | 17572523

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
38 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | alks-20231113_pre.xml | EX-101.PRE | 11098
39 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | alks-20231113.xsd | EX-101.SCH | 2474
40 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | alks-20231113_lab.xml | EX-101.LAB | 17722
42 | EXTRACTED XBRL INSTANCE DOCUMENT | alks-20231113_htm.xml | XML | 4683

Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35299 | Film No.: 231409019
SIC: 2834 Pharmaceutical Preparations